摘要:
Fluid compositions and methods for lubrication of mammalian joints are disclosed, including both natural and artificial fluids. Synovial fluid acts to lubricate the bearing surfaces of bones and bone-like structures which are held in frictional contact within biological joints. Such fluids may be used to treat arthritic, injured, and diseased joints. Synovial fluid containing a dextran-based hydrogel with lipids provides enhanced rheological and tribological properties of such a fluid. Phospholipids are particularly useful in dextran-based compositions for synovial fluid. One phospholipid that can be used advantageously in synovial fluid is dipalmitoyl phosphatidylcholine (DPPC).
摘要:
The invention relates to the incorporation of di-sugar alcohol phosphates of C3 to C6 sugar alcohols and/or derivatives of said compounds, e.g. acids, salts, or esters, into cosmetic or dermatological formulations for protecting the skin against environmental influences. The inventive low-molecular compounds of this type take part in the active cell protection of the cells' own free-radical scavengers, antioxidants, DNA, cell membranes and other cell compartments, protecting them against harmful environmental influences, e.g. UV radiation, IR radiation and environmental stress (thermal, chemical and physical). The compatible solution can act as a co-solvent and intensify the penetration of other active ingredients added to the cosmetic formulation, not only to stabilise said ingredients in the formulation, but also to actively transport them into deeper dermal layers.
摘要:
The present invention provides for pyrodoxine phosphonate analogues such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)alkylphosphonates, and (2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl)azaalkylphosphonates) and to pyridoxine malonates analogues, such as, for example, ((2-methyl-3-hydroxy-4-hydroxymethyl-5-pyridylmethyl)malonates), pharmaceutical compositions, and methods for treatment of cardiovascular and related diseases, and diabetes mellitus and related diseases.
摘要:
HETE salts, the preparation of HETE salts, the preparation of stable and efficacious HETE compositions, HETE compositions and methods of use for treating dry eye are disclosed.
摘要:
The present invention is related to an inhibitor of the inositol polyphosphate 5-phosphatase SHIP2 protein or its encoding nucleotide sequence identified by SEQ ID NO. 1 or of SHIP2 mRNA expression. The present invention is also related to a pharmaceutical composition comprising said inhibitor and an adequate pharmaceutically acceptable carrier or diluent and to a non-human knock-out mammal comprising homozygously or heterozygously a partial or total deletion in its genome of the inositol polyphoshate 5-phosphatase SHIP2 nucleotide sequence.
摘要翻译:本发明涉及一种多聚磷酸肌醇5磷酸酶SHIP2蛋白或其编码核苷酸序列的抑制剂,其由SEQ ID NO: 1或SHIP2 mRNA表达。 本发明还涉及包含所述抑制剂和足够的药学上可接受的载体或稀释剂和非人敲除的哺乳动物的药物组合物,其在其基因组中纯合或杂合地部分或全部缺失的肌醇多磷酸5-磷酸酶 SHIP2核苷酸序列。
摘要:
Preventives and remedies for neuron degeneration-associated diseases including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis which contain compounds represented by general formula (I) or pharmaceutically acceptable salts thereof, wherein R1 and R2 are the same or different and each represents hydrogen or methyl.
摘要:
This invention relates to a drug delivery composition, a self-emulsifying composition thereof and a method for producing the same for oral administration to enhance the normalisation of fatty liver. More particularly, the self-emulsifying composition comprises a non-ionic surfactant, a co-surfactant, vegetable oil and active ingredients comprising phospholipids, tocotrienols and tocopherols. The composition aforementioned works synergistically to provide an effectively delivered micronutrients and vitamins to the liver and also facilitate hepatic regeneration thereof.
摘要:
It is provided a method for stimulating the secretion of specialized pro-resolving mediators in a subject after the administration of a therapeutic phospholipid compositions such as CaPre®, wherein the composition also increases plasma levels of 17S-HDHA, PDX and 18RS-HEPE in the subject. Increased levels of protectins and resolvins are useful in protecting against many inflammatory-related diseases.